Compare Mutual Funds
Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 4/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 10 Years 6 Months | 13 Years 6 Months | ||
Fund AUM | ₹1229 Cr | ₹7898 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.72% | 0.93% | ||
Exit Load | 0.25% | 1% | ||
Benchmark Index | Nifty Pharma TR INR | BSE Healthcare TR INR |
No of Holdings | 40 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 3 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 99.69% | 99.46% | ||
Debt % | - | - | ||
P/E | 38.31 | 34.36 | ||
P/B | 5.88 | 5.45 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 11.1% | 10.04% | ||
3-Month Return | 8.22% | 7.93% | ||
6-Month Return | 1.94% | 4.43% | ||
1-Year Return | 8.62% | 9.49% | ||
3-Year Return | 25.46% | 24.71% | ||
5-Year Return | 15.54% | 14.55% |
Sharpe | 0.98 | 1.01 | ||
Alpha | 0.68 | -0.24 | ||
Beta | 0.98 | 0.91 | ||
Standard Deviation | 17.08 | 15.78 | ||
Information Ratio | 0.08 | -0.55 |
Description | Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rajat Srivastava | Sailesh Raj Bhan, Kinjal Desai, Amber Singhania |

